nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—nervous system—attention deficit hyperactivity disorder	0.208	0.237	CbGeAlD
Pentosan Polysulfate—FGF1—forebrain—attention deficit hyperactivity disorder	0.101	0.115	CbGeAlD
Pentosan Polysulfate—FGF2—midbrain—attention deficit hyperactivity disorder	0.0897	0.102	CbGeAlD
Pentosan Polysulfate—FGF1—cardiovascular system—attention deficit hyperactivity disorder	0.0854	0.0974	CbGeAlD
Pentosan Polysulfate—FGF2—cerebellum—attention deficit hyperactivity disorder	0.0694	0.0791	CbGeAlD
Pentosan Polysulfate—FGF1—midbrain—attention deficit hyperactivity disorder	0.0667	0.076	CbGeAlD
Pentosan Polysulfate—FGF2—brain—attention deficit hyperactivity disorder	0.0564	0.0643	CbGeAlD
Pentosan Polysulfate—FGF1—nervous system—attention deficit hyperactivity disorder	0.0548	0.0625	CbGeAlD
Pentosan Polysulfate—FGF1—central nervous system—attention deficit hyperactivity disorder	0.0528	0.0602	CbGeAlD
Pentosan Polysulfate—FGF1—cerebellum—attention deficit hyperactivity disorder	0.0516	0.0588	CbGeAlD
Pentosan Polysulfate—FGF1—brain—attention deficit hyperactivity disorder	0.0419	0.0478	CbGeAlD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—STUB1—attention deficit hyperactivity disorder	0.00885	0.0721	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.0081	0.066	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—STUB1—attention deficit hyperactivity disorder	0.00562	0.0458	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—STUB1—attention deficit hyperactivity disorder	0.00512	0.0418	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Mecp2 and Associated Rett Syndrome—BDNF—attention deficit hyperactivity disorder	0.00469	0.0382	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00466	0.038	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00332	0.0271	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.0032	0.0261	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00309	0.0252	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.00297	0.0242	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00296	0.0241	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.0027	0.022	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00244	0.0199	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.00241	0.0196	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00211	0.0172	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00196	0.016	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00194	0.0158	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00192	0.0157	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—STUB1—attention deficit hyperactivity disorder	0.00187	0.0153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00179	0.0146	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00178	0.0145	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—STUB1—attention deficit hyperactivity disorder	0.00173	0.0141	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.0017	0.0139	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00155	0.0127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00155	0.0127	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00155	0.0126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00142	0.0116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00141	0.0115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00125	0.0102	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00123	0.01	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00121	0.00988	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STUB1—attention deficit hyperactivity disorder	0.00119	0.0097	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00114	0.00933	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00112	0.00913	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STUB1—attention deficit hyperactivity disorder	0.0011	0.00896	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STUB1—attention deficit hyperactivity disorder	0.00108	0.00885	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00849	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00102	0.00832	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STUB1—attention deficit hyperactivity disorder	0.001	0.00817	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.001	0.00816	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000985	0.00803	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000902	0.00735	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000898	0.00733	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000822	0.0067	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SNAP25—attention deficit hyperactivity disorder	0.00082	0.00669	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000769	0.00627	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000762	0.00621	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000707	0.00577	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000701	0.00572	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000695	0.00567	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000661	0.00539	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000647	0.00528	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000635	0.00518	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000618	0.00504	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000603	0.00491	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00059	0.00481	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000579	0.00472	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000574	0.00468	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000556	0.00454	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000547	0.00446	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00054	0.0044	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000521	0.00425	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000503	0.0041	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000496	0.00404	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000475	0.00387	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000449	0.00366	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000409	0.00334	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000392	0.0032	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000365	0.00297	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000358	0.00292	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000353	0.00288	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000352	0.00287	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000347	0.00283	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000343	0.0028	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000333	0.00271	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000325	0.00265	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000322	0.00263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000319	0.0026	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000317	0.00258	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000315	0.00257	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000313	0.00255	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000291	0.00238	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EP300—attention deficit hyperactivity disorder	0.000289	0.00235	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000287	0.00234	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EP300—attention deficit hyperactivity disorder	0.000267	0.00217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000224	0.00182	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000204	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000187	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EP300—attention deficit hyperactivity disorder	0.000183	0.00149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EP300—attention deficit hyperactivity disorder	0.000169	0.00138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EP300—attention deficit hyperactivity disorder	0.000167	0.00136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EP300—attention deficit hyperactivity disorder	0.000154	0.00126	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000119	0.000966	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000108	0.000881	CbGpPWpGaD
